Oncokids pic38.png

Marta Príncep, PhD 

Chief Business Officer  


Marta Príncep has 20 years of experience in various management positions in the biomedical sector. She brings a long track record of drug discovery and development as Head of the CNS Department at Ferrer Grupo where she has created new research opportunities, including two drugs reaching the clinical phase. She has also been a member of the steering committee for international joint ventures.

Marta has also been the Director of Innovation and board member at Biocat, a biocluster organization in Catalonia that represents more than 1100 companies and entities. While at Biocat she was also Scientific Director of Bioemprendedor XXI, a member of the Healthcare Investment Forum and Director of the baseline report on biosciences in Catalonia.

Recently, Marta has been the VP of Operations of AdVentura Capital, and is currently the Director of Technology at Bellavista, where she coordinates activities related to innovation and entrepreneurship.

Marta holds a PhD in Biology and executive education training from the Wharton School in Pennsylvania and Advanced Management Program at ESADE Business School in Barcelona.